发明名称 |
Methods of treating hepatic encephalopathy |
摘要 |
The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin. |
申请公布号 |
US8969398(B2) |
申请公布日期 |
2015.03.03 |
申请号 |
US201313768617 |
申请日期 |
2013.02.15 |
申请人 |
Salix Pharmaceuticals, Ltd. |
发明人 |
Forbes William |
分类号 |
A61K31/437;A61K31/08;A61K31/352;A61K31/395;A61K31/4164;A61K31/426;A61K31/4439;A61K31/606;A61K31/7016;A61K31/785;A61K38/14;A61K38/31;A61K45/06 |
主分类号 |
A61K31/437 |
代理机构 |
McCarter & English LLP |
代理人 |
McCarter & English LLP ;Sparks Jonathan M.;DeGrazia Michael J. |
主权项 |
1. A method of decreasing a subject's risk of a hepatic encephalopathy (HE) breakthrough episode comprising administering rifaximin daily for a period of about 12 months or longer to a subject suffering from HE, thereby decreasing the subject's risk of an HE breakthrough episode, wherein a breakthrough episode is defined as an increase of the Conn score to Grade ≧2 or an increase in Conn score of 1 and asterixis grade of 1 for subjects having a baseline Conn score of 0. |
地址 |
Raleigh NC US |